Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01099 SINOPHARM
RT Nominal down25.050 -0.600 (-2.339%)
Latest  |  Final   |  Interim
2022/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
2018/12
RMB(K¥)
Turnover552,147,5505.968%521,051,235456,414,611425,272,726344,525,821
Cost of Sales(504,713,490)5.810%(477,000,627)(416,091,300)(387,741,423)(313,297,729)
Gross Profit47,434,0607.681%44,050,60840,323,31137,531,30331,228,092
 
Change in FV & Impairment on Inv. Prop.------------
Change in FV & Impairment on Others(666,467)11.360%(598,478)(750,224)(416,391)(357,336)
Profit / (Loss) on Disposal(1,936,170)71.218%(1,130,821)(1,273,561)(1,950,177)(1,328,832)
Other Non-operating Items82,278--(375,813)(202,327)(120,544)81,828
Share of Results of Asso. & JCEs1,067,067-0.262%1,069,868987,463887,074843,169
Profit / (Loss) before Taxation18,563,8199.179%17,003,16215,598,09613,759,81012,207,940
Taxation(4,218,377)7.109%(3,938,389)(3,500,805)(3,139,738)(2,803,456)
Profit / (Loss) from Discontinued Operations------------
Non-controlling Interests(5,819,787)9.681%(5,306,127)(4,910,013)(4,367,535)(3,568,642)
Others------------
Profit / (Loss) Attributable to Shareholders8,525,6559.886%7,758,6467,187,2786,252,5375,835,842
 
Net Finance Costs / (Income)3,189,992-6.256%3,402,8692,944,1893,137,4242,766,396
Depreciation & Amortisation4,165,0196.195%3,922,0583,597,1143,114,0761,394,679
Directors' Emoluments----15,27721,94225,46220,543
 
Auditor's Opinion StatusUnqualified--UnqualifiedUnqualifiedUnqualifiedUnqualified
Market Valuation Indicators
EPS (cts)273.000--249.000231.000211.000197.000
DPS (cts)82.000--75.00069.00060.00059.000
Dividend Payout Ratio (%)30.037%--30.120%29.870%28.436%29.949%
Cash flow per share ($)----2.9833.5856.3231.231
NBV per share ($)21.812--19.83118.06015.95814.410
Remarks:  Real time quote last updated: 31/05/2023 11:34
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service.
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 8,525,655
%Change9.886%
EPS / (LPS)RMB 2.730
NBV Per Share (¥)RMB 21.812
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2023 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.